Mashaparni

Names and identification

Language	Name
English	Mashaparni
Latin/Botanical	Teramnus labialis (L.f.) Spreng.

Key Phytochemical Constituents

• Vitexin (C-glycosyl flavone)
• Bergenin (C-glycoside of 4-O-methylgallic acid)
• Daidzin (isoflavone glycoside)
• 3-O-methyl-D-chiro-inositol
• Coumarins
• Free phenols and tannins
• Amino acids (lysine, leucine, isoleucine, arginine, valine, histidine)
• Unsaturated fatty acids

How does it work?

• Anti-inflammatory action primarily mediated by vitexin through dose-dependent inhibition of 5-lipoxygenase enzyme, reducing leukotriene synthesis
• Antidiabetic mechanism through improvement of insulin sensitivity, with coumarins-containing fraction showing efficacy in type 2 diabetes mouse models
• Immunomodulatory mechanism involving enhancement of both humoral and cell-mediated immune responses, demonstrated through antigen challenge models

Which traditional uses are supported by research?

• Anti-inflammatory activity validated through isolation of vitexin as a key 5-LOX inhibitor, confirming traditional use in inflammatory conditions and rheumatism
• Immunomodulatory properties experimentally confirmed, supporting traditional use as a body strengthener and vitality enhancer
• Antidiabetic potential supported by in vivo studies with coumarin-rich fractions, partially validating traditional use in Prameha (metabolic disorders)

What do recent clinical trials show?

3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

• Traditionally used safely in Ayurvedic formulations including Chyawanprash; high nutritional value with significant protein (22.86%), mineral, and amino acid content supports safety for dietary use
• No significant adverse effects documented in preclinical pharmacological studies; however, systematic toxicological evaluation is limited

Dosage forms and preparation

Dosage Forms: Churna (powder), Kwatha (decoction), Capsules, Tablets, Ghrita (medicated ghee), Taila (medicated oil)

Standard Dosage: 3-6 g whole plant powder per day; 50-100 mL decoction twice daily; 500 mg standardized extract twice daily

Bioavailability: Isoflavonoids show moderate oral bioavailability (20-30%). Genistein and daidzein (if present) are well-studied with known pharmacokinetics. Phytosterols are poorly absorbed (2-5%) but therapeutically active at the gut level. Ghrita-based preparations enhance absorption of lipophilic isoflavones significantly.

Optimal Timing: With meals for nutritive and tonic effects; morning with milk for Rasayana benefits; Taila application for musculoskeletal complaints

Standardized Extract: Whole plant extract (8:1 hydroalcoholic) standardized to minimum 1% total isoflavonoids. Ghrita preparation per classical texts. Combined Mashaparni-Mudgaparni extract for Jivaniya formulations.

Shelf Life: 24 months for dried powder; 30 months for capsules/tablets; 24 months for Ghrita; 36 months for Taila

Storage: Store below 25 deg C in airtight containers. Protect from moisture and light. Ghrita in glass containers at room temperature. Taila in amber glass bottles.

Marker Compounds: Genistein, Daidzein, Beta-sitosterol, Stigmasterol, Lupeol, Galactomannan, Flavonoid glycosides

Extraction Methods

• Aqueous decoction
• Hydroalcoholic extraction (60% ethanol)
• Oil extraction for Taila preparation
• Ghrita Paka method
• Methanol extraction for flavonoid enrichment

Synergistic Combinations

• Mudgaparni (classical pair in Jivaniya Gana)
• Bala (strength-building combination)
• Ashwagandha (musculoskeletal tonic)
• Shatavari (nutritive Rasayana)
• Dashamula (anti-Vata polyherbal)